Biotech

All Articles

Sanofi fails MS research, giving an additional strike to Denali contract

.Sanofi has actually quit a stage 2 ordeal of Denali Therapeutics-partnered oditrasertib in numerous...

Turnstone gives up 60%, agitates C-suite to extend cash

.Turnstone Biologics is lessening its own headcount by 60% as well as shaking up its own C-suite if ...

Gilead gives up on $15M MASH bet after mulling preclinical information

.In a year that has actually found an authorization as well as a boating of readouts for metabolic d...

Texas biotech axes cancer cells pact, pins really hopes on excessive weight

.Alaunos Rehabs is actually axing an arrangement with Precigen, quiting licensing legal rights to an...

Capricor allotments extra records for DMD treatment after initiating BLA

.Capricor Therapeutics is taking a success lap for their period 2 Duchenne muscular dystrophy (DMD) ...

FDA locations Kezar lupus test in grip adhering to 4 client deaths

.The FDA has put Kezar Lifestyle Sciences' lupus test on hold after the biotech hailed 4 deaths in t...

Phase 3 Scholar Rock trial hits SMA target, delivering stock up 200%

.A phase 3 test of Academic Rock's spinal muscle degeneration (SMA) candidate has actually reached i...

CAMP 4 is most recent to eye IPO, while Upstream spells out $182M plan

.RNA biotech CAMP4 Rehabs has actually defined plans for a $67 million IPO, along with inflammation-...

Galecto buys leukemia drug, goes down bone tissue cancer asset in pivot

.A year after the breakdown of an idiopathic pulmonary fibrosis applicant delivered Galecto on a hun...

Judo tosses down $100M to knock senseless kidney disease

.Taking the floor covering is Judo Biography, a promising biotech armed along with $100 thousand to ...